DK1495011T3 - Semisyntetisk fremgangsmåde til fremstilling af N-debenzoylpaclitaxel - Google Patents

Semisyntetisk fremgangsmåde til fremstilling af N-debenzoylpaclitaxel

Info

Publication number
DK1495011T3
DK1495011T3 DK03714874T DK03714874T DK1495011T3 DK 1495011 T3 DK1495011 T3 DK 1495011T3 DK 03714874 T DK03714874 T DK 03714874T DK 03714874 T DK03714874 T DK 03714874T DK 1495011 T3 DK1495011 T3 DK 1495011T3
Authority
DK
Denmark
Prior art keywords
preparation
semi
synthetic process
paclitaxel
formula
Prior art date
Application number
DK03714874T
Other languages
English (en)
Inventor
Ezio Bombardelli
Gabriele Fontana
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK1495011T3 publication Critical patent/DK1495011T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK03714874T 2002-04-12 2003-03-24 Semisyntetisk fremgangsmåde til fremstilling af N-debenzoylpaclitaxel DK1495011T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000782A ITMI20020782A1 (it) 2002-04-12 2002-04-12 Processo semisintetico per la preparazione di n-debenzoilpaclitaxel

Publications (1)

Publication Number Publication Date
DK1495011T3 true DK1495011T3 (da) 2006-05-15

Family

ID=11449694

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03714874T DK1495011T3 (da) 2002-04-12 2003-03-24 Semisyntetisk fremgangsmåde til fremstilling af N-debenzoylpaclitaxel

Country Status (18)

Country Link
US (1) US7053222B2 (da)
EP (1) EP1495011B1 (da)
JP (2) JP5197908B2 (da)
KR (2) KR20100036394A (da)
CN (1) CN1310897C (da)
AT (1) ATE314357T1 (da)
AU (1) AU2003219094B2 (da)
CA (1) CA2482131C (da)
DE (1) DE60303023T2 (da)
DK (1) DK1495011T3 (da)
ES (1) ES2254921T3 (da)
HK (1) HK1075661A1 (da)
IL (2) IL164486A0 (da)
IT (1) ITMI20020782A1 (da)
NO (1) NO328960B1 (da)
PL (1) PL209650B1 (da)
RU (1) RU2302415C2 (da)
WO (1) WO2003087077A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20020782A1 (it) * 2002-04-12 2003-10-13 Indena Spa Processo semisintetico per la preparazione di n-debenzoilpaclitaxel
US7446126B2 (en) 2004-10-08 2008-11-04 Indena S.P.A. Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
ITMI20050614A1 (it) * 2005-04-12 2006-10-13 Indena Spa Processo per la purificazione della 10-deacetilbaccatina iii dalla 10-deacetil-2-debenzoil-2-pentenoilbaccatina iii
WO2008074178A1 (fr) * 2006-11-23 2008-06-26 Shanghai Bailing Pharmaceutical Technology Co., Ltd Nouveau procédé de préparation de paclitaxel semi-synthétique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2155304C (en) * 1993-02-05 2010-07-20 Charles Swindell Syntheses of paclitaxel, analogs and intermediates with variable a-ring side chains
EP0912504B1 (en) * 1996-05-08 2002-09-11 PHARMACIA & UPJOHN COMPANY Oxazolidine ester
AU3740997A (en) * 1996-08-26 1998-03-19 Bristol-Myers Squibb Company Sulfenamide taxane derivatives
US5917062A (en) * 1997-11-21 1999-06-29 Indena S.P.A Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
ITMI20020782A1 (it) * 2002-04-12 2003-10-13 Indena Spa Processo semisintetico per la preparazione di n-debenzoilpaclitaxel

Also Published As

Publication number Publication date
US20050049297A1 (en) 2005-03-03
KR20040105795A (ko) 2004-12-16
NO328960B1 (no) 2010-06-28
PL209650B1 (pl) 2011-09-30
EP1495011B1 (en) 2005-12-28
KR20100036394A (ko) 2010-04-07
CN1310897C (zh) 2007-04-18
NO20044291L (no) 2004-10-11
WO2003087077A1 (en) 2003-10-23
CA2482131C (en) 2012-07-17
RU2302415C2 (ru) 2007-07-10
ES2254921T3 (es) 2006-06-16
DE60303023T2 (de) 2006-09-28
KR101159837B1 (ko) 2012-06-25
JP5197908B2 (ja) 2013-05-15
IL164486A (en) 2008-11-26
JP2005530729A (ja) 2005-10-13
ITMI20020782A1 (it) 2003-10-13
CN1646512A (zh) 2005-07-27
PL371673A1 (en) 2005-06-27
AU2003219094A1 (en) 2003-10-27
IL164486A0 (en) 2005-12-18
US7053222B2 (en) 2006-05-30
AU2003219094B2 (en) 2008-06-26
ITMI20020782A0 (it) 2002-04-12
JP2010265274A (ja) 2010-11-25
DE60303023D1 (de) 2006-02-02
EP1495011A1 (en) 2005-01-12
HK1075661A1 (en) 2005-12-23
CA2482131A1 (en) 2003-10-23
ATE314357T1 (de) 2006-01-15
RU2004130316A (ru) 2005-06-27

Similar Documents

Publication Publication Date Title
CY1107846T1 (el) Παραγωγα κιναζολινονης χρησιμα ως βανιλλοειδεις ανταγωνιστες
DK1511732T5 (da) Fremgangsmåde til fremstilling af quinolinderivater
DK1954264T3 (da) Fremgangsmåde til fremstilling af epoxybutanol-mellemprodukter
ATE451360T1 (de) Halbsynthetisches verfahren zur herstellung von 10-desacetyl-n-desbenzoyl-paclitaxel
FI941286A0 (fi) Uusia beta-laktaameja, menetelmiä taksaanien ja sivuketjullisten taksaanien valmistamiseksi
DE60123911D1 (de) Verfahren zur Herstellung von Aryloctanoyl-amiden
DE60131927D1 (de) Heterosubstituierte taxan-c10-acetate als antitumormittel
WO2004033442A3 (en) Novel taxanes and methods related to use and preparation thereof
HK1075661A1 (en) A semi-synthetic process for the preparation of n debenzoylpaclitavel
EA200700064A1 (ru) Способ получения эфиров 4,4-дифтор-3-оксобутановой кислоты
DE60001265T2 (de) Verfahren zu herstellung von taxanen aus 10-desacetylbaccatin iii
DE602007012930D1 (de) Phenanthrolinverbindungen und elektrolumineszensbauelemente damit
DK1741716T3 (da) Fremgangsmåde til fremstilling af pentacyklisk taxan
DE60010476D1 (de) Verfahren zur Herstellung eines C-4-Methylcarbonat-Analogons von Paclitaxel
EP1221445A4 (en) TAXANE PENTACYCLIC COMPOUNDS
ATE277898T1 (de) Verfahren zu herstellung von taxol
DK1383754T3 (da) Fremgangsmåde til syntetisering af taxanderivater
CR7832A (es) Tritiocarbonatos de cianometilo como nematicidas
DK1961735T3 (da) Fremgangsmåde til fremstilling af (2R,3S)-3-phenylisoserinmethylesteracetatsalt
DE60236303D1 (de) Verfahren zur herstellung von 14-beta-hydroxybaccatin-iii-1,14-carbonat
ATE378340T1 (de) Verfahren zur herstellung von 2,6-dihalogenpurin
AR046571A1 (es) Derivados de acido acremonico
RU2004137709A (ru) Способ получения 3-индолилфенилметил 2-замещенных циклических альфа-кетонов
ATE260265T1 (de) Herstellung von chiralen cis-5-amino-2- cyclopenten-1-ol derivaten
TH85801B (th) สารประกอบเฮทเทอโรไซคลิก แอนติไวรัส